New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
10:03 EDTDELL, CG, MS, SLW, PDCE, EXPR, EA, HRC, PVA, MMC, GCI, CHD, ITRI, DO, AGNOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Allergan (AGN) upgraded to Outperform from Market Perform at JMP Securities... Carlyle Group (CG) upgraded to Buy from Neutral at Citigroup... Dell (DELL) upgraded to Neutral from Sell at Citigroup... Express (EXPR) upgraded to Overweight from Neutral at JPMorgan... Gannett (GCI) upgraded to Buy from Neutral at Citigroup... Marsh & McLennan (MMC) upgraded to Buy from Neutral at Goldman... PDC Energy (PDCE) upgraded to Buy from Hold at Miller Tabak... Diamond Offshore (DO) upgraded to Outperform from Sector Perform at Iberia... Penn Virginia (PVA) upgraded to Outperform from Sector Perform at Howard Weil... Silver Wheaton (SLW) upgraded to Outperform from Neutral at Credit Suisse... Itron (ITRI) upgraded to Buy from Hold at Argus... Hill-Rom (HRC) upgraded to Conviction Buy from Buy at Goldman... Morgan Stanley (MS) upgraded to Neutral from Reduce at SunTrust... Church & Dwight (CHD) upgraded to Outperform from Underperform at CLSA... Electronic Arts (EA) upgraded to Buy from Neutral at Sterne Agee.
News For AGN;CG;GCI;EXPR;DELL;MMC;PDCE;DO;PVA;SLW;ITRI;HRC;MS;CHD;EA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
November 13, 2014
15:45 EDTDOHalliburton, Baker Hughes in fast-moving merger talks, WSJ reports
Subscribe for More Information
07:38 EDTGCIBloomberg Link to hold a conference
The Year Ahead: 2015 is being held in Washington, D.C. with a pre-conference dinner on November 13 followed by company presentations on November 14,
07:23 EDTAGNValeant wooing doctors ahead of hoped for Allergan acquisition, WSJ says
Subscribe for More Information
November 12, 2014
16:53 EDTAGNAllergan receives FDA approval for new styles of NATRELLE 410
Subscribe for More Information
13:54 EDTCGCarlyle Group interested in Serco units for sale, Sky News reports
Subscribe for More Information
10:46 EDTMSMorgan Stanley's Kelleher says Europe needs viable securitization framework
Subscribe for More Information
10:37 EDTMSMorgan Stanley's Kelleher says firm is negative on Europe for growth
The company's President, Institutional securities Colm Kelleher is speaking at the BofA Financial Services Conference.
10:09 EDTAGNActavis in talks to buy Allergan for over $200 per share, Bloomberg says
Subscribe for More Information
10:01 EDTAGNActavis in talks to buy Allergan for $60B, more than $200/share Bloomberg says
Actavis (ACT) is said to seek to pay about $200 per share, but Allergan (AGN) seeks about $210 per share, according to Bloomberg.
08:34 EDTSLWSilver Wheaton reports Q3 adjusted EPS 20c, consensus 21c
Reports Q3 revenue $165.9M, consensus $177.28M. Reports Q3 attributable silver equivalent production 8.4M - 6.1M ounces of silver and 35,400 ounces of gold, dwn 7% vs. 3Q13. Reports Q3 attributable silver equivalent sales volume 8.7M ounces - 6.3M ounces of silver and 36,700 ounces of gold -, up 12% vs. 3Q13. Reports Q3 average realized sale price per silver equivalent ounce sold of $18.98, down 11% vs. 3Q13.
07:28 EDTMS, CGBofA/Merrill to hold a conference
Subscribe for More Information
07:01 EDTAGNAllergan announces approval of amendments to company bylaws
Subscribe for More Information
06:36 EDTSLWSilver Wheaton reports Q3 adjusted EPS 20c, consensus 21c
Subscribe for More Information
06:22 EDTAGNZoetis price target raised to $49 from $44 at Citigroup
Citigroup raised its price target for Zoetis (ZTS) shares to $49 after activist Pershing Square confirmed the accumulation of a 10% stake in the company. Citi thinks Pershing is interested in advocating for a sale of Zoetis, potentially to Valeant (VRX) if its bid for Allergan (AGN) fails. Citi believes others, including Bayer (BAYRY), could be interested in acquiring Zoetis. It keeps a Buy rating on the stock.
November 11, 2014
15:46 EDTAGNPershing Square, Sachem Head build 10% stake in Zoetis, WSJ reports
Subscribe for More Information
08:32 EDTAGNValeant likely to raise offer for Allergan again, says Bernstein
Subscribe for More Information
November 10, 2014
15:43 EDTDELLAmerican Petroleum Institute to hold a conference
Subscribe for More Information
07:43 EDTSLWSilver Wheaton volatility elevated into Q3 and outlook
Silver Wheaton November call option implied volatility is at 48, December is at 45, January is at 48; compared to it 26-week average of 39 according to Track Data, suggesting large near term price movement into the expected release of Q3 on November 20.
06:46 EDTMSRegulators set new capital buffer rule for banks, Reuters reports
Global banks should have buffers of bonds or equity worth 16%-20% of their risk-weighted assets, beginning in January 2019, The Financial Stability Board decided, according to Reuters. The board said the buffer would prevent the need for government bailouts, the news service explained. Publicly traded global banks include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) Wells Fargo (WFC), Banco Santander (SAN), Barclays (BCS), Credit Suisse (CS), Deutsche Bank (DB), HSBC (HSBC), ING Groep (ING), Lloyds Banking (LYG), RBS (RBS) and UBS (UBS). Reference Link
November 9, 2014
13:26 EDTAGNAckman's Allergan court win may prove costly down the road, Bloomberg says
When U.S. District Court Judge David Carter ruled on November 4 that Pershing Square can vote its 9.7% stake in Allergan (AGN) in a shareholder ballot aiming to remove Allergan directors, he also noted that there were “serious questions” regarding insider trading rules in the way Pershing Square acquired Allergan stock while preparing a bid with Valeant (VRX), says Bloomberg. Reference Link
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use